Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

Characteristics of a hepatitis C patient cohort at a specialized tertiary care facility: Identifying criteria to improve the allocation of public health resources.

de Matos MLM, Ferrufino RQ, Nastri ACSS, Odongo FCA, Campos AF, Luiz AM, Lisboa-Neto G, Witkin SS, Mendes-Correa MC.

Clinics (Sao Paulo). 2019 Oct 28;74:e1286. doi: 10.6061/clinics/2019/e1286. eCollection 2019.

2.

Exploratory spatial analysis of HBV cases in Brazil between 2005 and 2017.

Vivaldini SM, Pinto FKA, Kohiyama IM, Almeida EC, Mendes-Correa MC, Santos AF, Ribeiro RA, Pereira GFM, Araújo WN.

Rev Bras Epidemiol. 2019 Sep 26;22Suppl 1(Suppl 1):e190007. doi: 10.1590/1980-549720190007.supl.1. eCollection 2019. English, Portuguese.

3.

Hepatitis C disease burden and strategies for elimination by 2030 in Brazil. A mathematical modeling approach.

Benzaken AS, Girade R, Catapan E, Pereira GFM, Almeida EC, Vivaldini S, Fernandes N, Razavi H, Schmelzer J, Ferraz ML, Ferreira PRA, Pessoa MG, Martinelli A, Souto FJD, Walsh N, Mendes-Correa MC.

Braz J Infect Dis. 2019 May - Jun;23(3):182-190. doi: 10.1016/j.bjid.2019.04.010. Epub 2019 May 27.

4.

Zika virus infection among symptomatic patients from two healthcare centers in Sao Paulo State, Brazil: prevalence, clinical characteristics, viral detection in body fluids and serodynamics.

Tozetto-Mendoza TR, Avelino-Silva VI, Fonseca S, Claro IM, Paula AV, Levin AS, Sabino EC, Mendes-Correa MC, Figueiredo WM, Felix AC, Souza NCS, Costa AA, Inenami M, Silva RMGD, Levi JE, Romano CM, Paranhos-Baccalà G, Segurado AC, Mayaud P.

Rev Inst Med Trop Sao Paulo. 2019;61:e19. doi: 10.1590/S1678-9946201961019. Epub 2019 Apr 4.

5.

How are HCV-infected patients being identified in Brazil: a multicenter study.

Portari-Filho LH, Álvares-da-Silva MR, Gonzalez A, Ferreira AP, Villela-Nogueira CA, Mendes-Correa MC, Lima JM, Lopes EP, Brandão CE, Ivantes C, Lyra A, Lindenberg A, Ferraz ML.

Braz J Infect Dis. 2019 Jan - Feb;23(1):34-39. doi: 10.1016/j.bjid.2019.01.006. Epub 2019 Mar 6.

6.

Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir ± Ribavirin for HCV in Brazilian Adults with Advanced Fibrosis.

Pessoa MG, Ramalho-Madruga JV, Alves K, Nunes EP, Cheinquer H, Brandão-Mello CE, Mendes-Correa MC, Ferraz ML, Ferreira PRA, Álvares-da-Silva MR, Coelho HS, Affonso-de-Araújo ES, Furtado J, Parana R, Silva G, Lari SA, Liu L, Tripathi R, Pilot-Matias T, Cohen DE, Shulman NS, Martinelli A.

Ann Hepatol. 2018 Oct 16;17(6):959-968. doi: 10.5604/01.3001.0012.7196.

7.

Fluctuations in serological hepatitis C virus levels in HIV patients.

Silva VCM, Calux SJ, Lemos MF, Compri AP, Santos APT, Oba IT, Mendes-Correa MCJ, Moreira RC.

Rev Soc Bras Med Trop. 2018 Nov-Dec;51(6):737-741. doi: 10.1590/0037-8682-0239-2018.

8.

Potential effect of Zika virus infection on human male fertility?

Avelino-Silva VI, Alvarenga C, Abreu C, Tozetto-Mendoza TR, Canto CLMD, Manuli ER, Mendes-Correa MC, Sabino EC, Figueiredo WM, Segurado AC, Mayaud P.

Rev Inst Med Trop Sao Paulo. 2018 Oct 25;60:e64. doi: 10.1590/S1678-9946201860064.

9.

Prevalence of naturally occurring amino acid substitutions associated with resistance to hepatitis C virus NS3/NS4A protease inhibitors in São Paulo state.

Moreira RC, de Torres Santos AP, Lisboa-Neto G, Mendes-Corrêa MCJ, Lemos MF, Malta FM, Santana RAF, Dastoli GTF, de Castro VFD, Pinho JRR.

Arch Virol. 2018 Oct;163(10):2757-2764. doi: 10.1007/s00705-018-3920-9. Epub 2018 Jun 30.

PMID:
29961118
10.

Prevalence of naturally occurring NS5A resistance-associated substitutions in patients infected with hepatitis C virus subtype 1a, 1b, and 3a, co-infected or not with HIV in Brazil.

Malta F, Gaspareto KV, Lisboa-Neto G, Carrilho FJ, Mendes-Correa MC, Pinho JRR.

BMC Infect Dis. 2017 Nov 13;17(1):716. doi: 10.1186/s12879-017-2817-7.

11.

Peginterferon still has a place in the treatment of hepatitis C caused by genotype 3 virus.

Grando AV, Ferreira PRA, Pessôa MG, Mazo DFC, Brandão-Mello CE, Reuter T, Martinelli ALC, Gonzalez MP, Nastri ACS, Campos AF, Lopes MIBF, Brito JDU, Mendes-Corrêa MC.

Rev Inst Med Trop Sao Paulo. 2017 Nov 6;59:e67. doi: 10.1590/S1678-9946201759067.

12.

Serological and molecular markers of hepatitis E virus infection in HIV-infected patients in Brazil.

Ferreira AC, Gomes-Gouvêa MS, Lisboa-Neto G, Mendes-Correa MCJ, Picone CM, Salles NA, Mendrone-Junior A, Carrilho FJ, Pinho JRR.

Arch Virol. 2018 Jan;163(1):43-49. doi: 10.1007/s00705-017-3562-3. Epub 2017 Sep 30.

PMID:
28965214
13.

Characterization of clinical predictors of naturally occurring NS3/NS4A protease polymorphism in genotype 1 hepatitis C virus mono and HIV co-infected patients.

Lisboa Neto G, Malta FM, Gomes-Gouvêa MS, Noble CF, Romano CM, Rebello Pinho JR, Silva MH, Leite AGB, Piccoli LZ, Carrilho FJ, Mendes-Correa MC.

J Med Virol. 2017 Dec;89(12):2249-2254. doi: 10.1002/jmv.24900. Epub 2017 Aug 11.

PMID:
28700085
14.

Effectiveness and safety of first-generation protease inhibitors in real-world patients with hepatitis C virus genotype 1 infection in Brazil: a multicenter study.

Callefi LA, Villela-Nogueira CA, de Barros Tenore S, Carnaúba-Júnior D, Coelho HSM, Pinto PTA, Nabuco LC, Pessoa MG, Ferraz MLCG, Ferreira PRA, de Lourdes Candolo Martinelli A, Chachá SGF, de Souza Paiva Ferreira A, de Macedo Bisio AP, Brandão-Mello CE, Álvares-Da-Silva MR, Reuter T, Ivantes CAP, de Mello Perez R, Mendes-Correa MCJ.

Clinics (Sao Paulo). 2017 Jun;72(6):378-385. doi: 10.6061/clinics/2017(06)08.

15.

Establishment and cryptic transmission of Zika virus in Brazil and the Americas.

Faria NR, Quick J, Claro IM, Thézé J, de Jesus JG, Giovanetti M, Kraemer MUG, Hill SC, Black A, da Costa AC, Franco LC, Silva SP, Wu CH, Raghwani J, Cauchemez S, du Plessis L, Verotti MP, de Oliveira WK, Carmo EH, Coelho GE, Santelli ACFS, Vinhal LC, Henriques CM, Simpson JT, Loose M, Andersen KG, Grubaugh ND, Somasekar S, Chiu CY, Muñoz-Medina JE, Gonzalez-Bonilla CR, Arias CF, Lewis-Ximenez LL, Baylis SA, Chieppe AO, Aguiar SF, Fernandes CA, Lemos PS, Nascimento BLS, Monteiro HAO, Siqueira IC, de Queiroz MG, de Souza TR, Bezerra JF, Lemos MR, Pereira GF, Loudal D, Moura LC, Dhalia R, França RF, Magalhães T, Marques ET Jr, Jaenisch T, Wallau GL, de Lima MC, Nascimento V, de Cerqueira EM, de Lima MM, Mascarenhas DL, Neto JPM, Levin AS, Tozetto-Mendoza TR, Fonseca SN, Mendes-Correa MC, Milagres FP, Segurado A, Holmes EC, Rambaut A, Bedford T, Nunes MRT, Sabino EC, Alcantara LCJ, Loman NJ, Pybus OG.

Nature. 2017 Jun 15;546(7658):406-410. doi: 10.1038/nature22401. Epub 2017 May 24.

16.

Hepatitis C among blood donors: cascade of care and predictors of loss to follow-up.

Machado SM, Almeida C Neto, Pinho JRR, Malta FM, Capuani L, Campos AF, Abreu FRM, Nastri ACSS, Santana RAF, Sabino EC, Mendes-Correa MC.

Rev Saude Publica. 2017 Apr 27;51(0):40. doi: 10.1590/S1518-8787.2017051006468.

17.

Persistence of Zika Virus in Breast Milk after Infection in Late Stage of Pregnancy.

Sotelo JR, Sotelo AB, Sotelo FJB, Doi AM, Pinho JRR, Oliveira RC, Bezerra AMPS, Deutsch AD, Villas-Boas LS, Felix AC, Romano CM, Machado CM, Mendes-Correa MCJ, Santana RAF, Menezes FG, Mangueira CLP.

Emerg Infect Dis. 2017 May;23(5):856-857. doi: 10.3201/eid2305.161538. Epub 2017 May 15.

18.

Natural occurrence of NS5B inhibitor resistance-associated variants in Brazilian patients infected with HCV or HCV and HIV.

Noble CF, Malta F, Lisboa-Neto G, Gomes-Gouvêa MS, Leite AGB, de Castro VFD, Santana RAF, Carrilho FJ, Mendes-Correa MC, Pinho JRR.

Arch Virol. 2017 Jan;162(1):165-169. doi: 10.1007/s00705-016-3094-2. Epub 2016 Oct 4.

PMID:
27704215
19.

Resistance-associated variants in HCV subtypes 1a and 1b detected by Ion Torrent sequencing platform.

Gaspareto KV, Ribeiro RM, de Mello Malta F, Gomes-Gouvêa MS, Muto NH, Romano CM, Mendes-Correa MC, Carrilho FJ, Sabino EC, Rebello Pinho JR.

Antivir Ther. 2016;21(8):653-660. doi: 10.3851/IMP3057. Epub 2016 Jun 17.

PMID:
27314166
20.

HCV inter-subtype 1a/1b recombinant detected by complete-genome next-generation sequencing.

Gaspareto KV, Ribeiro RM, de Mello Malta F, Gomes-Gouvêa MS, Muto NH, Mendes-Correa MC, Rozanski A, Carrilho FJ, Sabino EC, Pinho JR.

Arch Virol. 2016 Aug;161(8):2161-8. doi: 10.1007/s00705-016-2889-5. Epub 2016 May 18.

PMID:
27194536
21.

High incidence of tuberculosis in patients treated for hepatitis C chronic infection.

de Oliveira Uehara SN, Emori CT, Perez RM, Mendes-Correa MC, de Souza Paiva Ferreira A, de Castro Amaral Feldner AC, Silva AE, Filho RJ, de Souza E Silva IS, Ferraz ML.

Braz J Infect Dis. 2016 Mar-Apr;20(2):205-9. doi: 10.1016/j.bjid.2015.12.003. Epub 2016 Feb 9.

22.

Hepatic peroxisome proliferator-activated receptor γ and α-mRNA expression in HCV-infected adults is decreased by HIV co-infection and is also affected by ethnicity.

Shores NJ, Mendes-Corrêa MC, Maida I, Turner J, High KP, Babudieri S, Núãez M.

Clinics (Sao Paulo). 2015 Dec;70(12):790-6. doi: 10.6061/clinics/2015(12)05.

23.

Drug-induced liver injury in hospitalized HIV patients: high incidence and association with drugs for tuberculosis.

Tomich LG, Núñez M, Mendes-Correa MC.

Ann Hepatol. 2015 Nov-Dec;14(6):888-94. doi: 10.5604/16652681.1171778.

24.

Extended treatment with pegylated interferon alfa/ribavirin in patients with genotype 2/3 chronic hepatitis C who do not achieve a rapid virological response: final analysis of the randomised N-CORE trial.

Shiffman ML, Cheinquer H, Berg CP, Berg T, de Figueiredo-Mendes C, Dore GJ, Ferraz ML, Mendes-Corrêa MC, Lima MP, Parise ER, Rios AM, Reuter T, Sanyal AJ, Shafran SD, Hohmann M, Tatsch F, Bakalos G, Zeuzem S.

Hepatol Int. 2014 Oct;8(4):517-26. doi: 10.1007/s12072-014-9555-3. Epub 2014 Jul 24.

PMID:
26202757
25.

Fibrosis Progression in Paired Liver Biopsies from HIV/HCV-Coinfected Patients without Prior Treatment of Hepatitis C.

Leite AG, Duarte MI, Mendes-Correa MC.

J Int Assoc Provid AIDS Care. 2015 Sep-Oct;14(5):463-8. doi: 10.1177/2325957415587571. Epub 2015 Jun 8.

PMID:
26056147
26.

Disease burden of chronic hepatitis C in Brazil.

Ferreira PR, Brandão-Mello CE, Estes C, Gonçales Júnior FL, Coelho HS, Razavi H, Cheinquer H, Wolff FH, Ferraz ML, Pessoa MG, Mendes-Correa MC.

Braz J Infect Dis. 2015 Jul-Aug;19(4):363-8. doi: 10.1016/j.bjid.2015.04.004. Epub 2015 Jun 4.

27.

HBV carrying drug-resistance mutations in chronically infected treatment-naive patients.

Gomes-Gouvêa MS, Ferreira AC, Teixeira R, Andrade JR, Ferreira AS, Barros LM, Rezende RE, Nastri AC, Leite AG, Piccoli LZ, Galvan J, Conde SR, Soares MC, Kliemann DA, Bertolini DA, Kunyoshi AS, Lyra AC, Oikawa MK, de Araújo LV, Carrilho FJ, Mendes-Corrêa MC, Pinho JR.

Antivir Ther. 2015;20(4):387-95. doi: 10.3851/IMP2938. Epub 2015 Jan 27.

PMID:
25624410
28.

Resistance mutations are rare among protease inhibitor treatment-naive hepatitis C genotype-1 patients with or without HIV coinfection.

Lisboa-Neto G, Noble CF, Pinho JR, Malta FM, Gomes-Gouvêa MS, Alvarado-Mora MV, da Silva MH, Leite AG, Piccoli LZ, Rodrigues FK, Carrilho FJ, Mendes-Correa MC.

Antivir Ther. 2015;20(3):281-7. doi: 10.3851/IMP2873. Epub 2014 Oct 3.

PMID:
25279715
29.

Latin American Association for the Study of the Liver recommendations on treatment of hepatitis C.

Méndez-Sánchez N, Paraná R, Cheinquer H, Alves de Mattos A, Gadano A, Silva M, Pessôa MG, Gomes-Ferraz ML, Soza A, Mendes-Correa MC, Chávez-Tapia NC, Dagher L, Padilla M, Hernandez N, Sánchez-Avila JF, Contreras F, Moraes-Coelho HS, Parise ER, Bessone F, Uribe M; Latin American Association for the Study of the Liver.

Ann Hepatol. 2014 Aug;13 Suppl 2:s4-66. Review. No abstract available.

30.

The clinical effectiveness of pegylated interferon and ribavirin for the treatment of chronic hepatitis C in HIV-infected patients in Brazil: a multicentric study.

Ferreira PR, Silva MH, Brandão-Melo CE, Rezende RE, Gonzalez M, Reuter T, Urbaez JD, Gianini RJ, Martinelli A, Mendes-Correa MC.

Braz J Infect Dis. 2015 Jan-Feb;19(1):15-22. doi: 10.1016/j.bjid.2014.08.002. Epub 2014 Sep 1.

31.

Strategies to manage hepatitis C virus (HCV) disease burden.

Wedemeyer H, Duberg AS, Buti M, Rosenberg WM, Frankova S, Esmat G, Örmeci N, Van Vlierberghe H, Gschwantler M, Akarca U, Aleman S, Balık I, Berg T, Bihl F, Bilodeau M, Blasco AJ, Brandão Mello CE, Bruggmann P, Calinas F, Calleja JL, Cheinquer H, Christensen PB, Clausen M, Coelho HS, Cornberg M, Cramp ME, Dore GJ, Doss W, El-Sayed MH, Ergör G, Estes C, Falconer K, Félix J, Ferraz ML, Ferreira PR, García-Samaniego J, Gerstoft J, Giria JA, Gonçales FL Jr, Guimarães Pessôa M, Hézode C, Hindman SJ, Hofer H, Husa P, Idilman R, Kåberg M, Kaita KD, Kautz A, Kaymakoglu S, Krajden M, Krarup H, Laleman W, Lavanchy D, Lázaro P, Marinho RT, Marotta P, Mauss S, Mendes Correa MC, Moreno C, Müllhaupt B, Myers RP, Nemecek V, Øvrehus AL, Parkes J, Peltekian KM, Ramji A, Razavi H, Reis N, Roberts SK, Roudot-Thoraval F, Ryder SD, Sarmento-Castro R, Sarrazin C, Semela D, Sherman M, Shiha GE, Sperl J, Stärkel P, Stauber RE, Thompson AJ, Urbanek P, Van Damme P, van Thiel I, Vandijck D, Vogel W, Waked I, Weis N, Wiegand J, Yosry A, Zekry A, Negro F, Sievert W, Gower E.

J Viral Hepat. 2014 May;21 Suppl 1:60-89. doi: 10.1111/jvh.12249.

PMID:
24713006
32.

The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm.

Razavi H, Waked I, Sarrazin C, Myers RP, Idilman R, Calinas F, Vogel W, Mendes Correa MC, Hézode C, Lázaro P, Akarca U, Aleman S, Balık I, Berg T, Bihl F, Bilodeau M, Blasco AJ, Brandão Mello CE, Bruggmann P, Buti M, Calleja JL, Cheinquer H, Christensen PB, Clausen M, Coelho HS, Cramp ME, Dore GJ, Doss W, Duberg AS, El-Sayed MH, Ergör G, Esmat G, Falconer K, Félix J, Ferraz ML, Ferreira PR, Frankova S, García-Samaniego J, Gerstoft J, Giria JA, Gonçales FL Jr, Gower E, Gschwantler M, Guimarães Pessôa M, Hindman SJ, Hofer H, Husa P, Kåberg M, Kaita KD, Kautz A, Kaymakoglu S, Krajden M, Krarup H, Laleman W, Lavanchy D, Marinho RT, Marotta P, Mauss S, Moreno C, Murphy K, Negro F, Nemecek V, Örmeci N, Øvrehus AL, Parkes J, Pasini K, Peltekian KM, Ramji A, Reis N, Roberts SK, Rosenberg WM, Roudot-Thoraval F, Ryder SD, Sarmento-Castro R, Semela D, Sherman M, Shiha GE, Sievert W, Sperl J, Stärkel P, Stauber RE, Thompson AJ, Urbanek P, Van Damme P, van Thiel I, Van Vlierberghe H, Vandijck D, Wedemeyer H, Weis N, Wiegand J, Yosry A, Zekry A, Cornberg M, Müllhaupt B, Estes C.

J Viral Hepat. 2014 May;21 Suppl 1:34-59. doi: 10.1111/jvh.12248.

PMID:
24713005
33.

Historical epidemiology of hepatitis C virus (HCV) in selected countries.

Bruggmann P, Berg T, Øvrehus AL, Moreno C, Brandão Mello CE, Roudot-Thoraval F, Marinho RT, Sherman M, Ryder SD, Sperl J, Akarca U, Balık I, Bihl F, Bilodeau M, Blasco AJ, Buti M, Calinas F, Calleja JL, Cheinquer H, Christensen PB, Clausen M, Coelho HS, Cornberg M, Cramp ME, Dore GJ, Doss W, Duberg AS, El-Sayed MH, Ergör G, Esmat G, Estes C, Falconer K, Félix J, Ferraz ML, Ferreira PR, Frankova S, García-Samaniego J, Gerstoft J, Giria JA, Gonçales FL Jr, Gower E, Gschwantler M, Guimarães Pessôa M, Hézode C, Hofer H, Husa P, Idilman R, Kåberg M, Kaita KD, Kautz A, Kaymakoglu S, Krajden M, Krarup H, Laleman W, Lavanchy D, Lázaro P, Marotta P, Mauss S, Mendes Correa MC, Müllhaupt B, Myers RP, Negro F, Nemecek V, Örmeci N, Parkes J, Peltekian KM, Ramji A, Razavi H, Reis N, Roberts SK, Rosenberg WM, Sarmento-Castro R, Sarrazin C, Semela D, Shiha GE, Sievert W, Stärkel P, Stauber RE, Thompson AJ, Urbanek P, van Thiel I, Van Vlierberghe H, Vandijck D, Vogel W, Waked I, Wedemeyer H, Weis N, Wiegand J, Yosry A, Zekry A, Van Damme P, Aleman S, Hindman SJ.

J Viral Hepat. 2014 May;21 Suppl 1:5-33. doi: 10.1111/jvh.12247. Review.

PMID:
24713004
34.

Prevalence, risk factors and genotypes of hepatitis B infection among HIV-infected patients in the State of MS, Central Brazil.

Freitas SZ, Soares CC, Tanaka TS, Lindenberg AS, Teles SA, Torres MS, Mello FC, Mendes-Corrêa MC, Savassi-Ribas F, Motta-Castro AR.

Braz J Infect Dis. 2014 Sep-Oct;18(5):473-80. doi: 10.1016/j.bjid.2014.01.005. Epub 2014 Mar 22.

35.

High prevalence of hepatitis B virus subgenotypes A1 and D4 in Maranhão state, Northeast Brazil.

Barros LM, Gomes-Gouvêa MS, Kramvis A, Mendes-Corrêa MC, dos Santos A, Souza LA, Santos MD, Carrilho FJ, de Jesus Domicini A, Pinho JR, de Souza Paiva Ferreira A.

Infect Genet Evol. 2014 Jun;24:68-75. doi: 10.1016/j.meegid.2014.03.007. Epub 2014 Mar 16.

PMID:
24642137
36.

Absence of anti-hepatitis B virus (HBV) core in HIV/HBV coinfection with advanced immunosuppression.

Avelino-Silva VI, Miraglia JL, Gomes-Gouvêa MS, Pinho JR, Mendes-Corrêa MC.

HIV Med. 2013 Aug;14(7):453-4. doi: 10.1111/hiv.12040. No abstract available.

37.

Viral hepatitis and HIV: update and management.

Núñez M, Mendes-Correa MC.

Antivir Ther. 2013;18(3 Pt B):451-8. doi: 10.3851/IMP2601. Epub 2013 Jun 21. Review.

PMID:
23792670
38.

Strong correlation by ultrasonography of hepatomegaly and the presence of co-infection in HIV/HCV cirrhotic patients.

Vezozzo DC, Mendes-Correa MC, Cunha-Silva M, Alvarado-Mora MV, França JÍ, Sebba JL, Nicodemo AC, Oliveira CP, Carrilho FJ.

Braz J Infect Dis. 2013 Mar-Apr;17(2):150-5. doi: 10.1016/j.bjid.2012.09.009. Epub 2013 Feb 27.

39.

Response predictors and clinical benefits of hepatitis C retreatment with pegylated interferon and ribavirin in HIV/HCV coinfection.

Peribañez-Gonzalez M, da Silva MH, Vilar FC, Seixas-Santos Nastri AC, Ferreira PA, Focaccia R, Mendes Correa MC.

Ann Hepatol. 2013 Mar-Apr;12(2):228-35.

40.

Thyroid disturbance related to chronic hepatitis C infection: role of CXCL10.

Danilovic DL, Mendes-Correa MC, Chammas MC, Zambrini H, Barros RK, Marui S.

Endocr J. 2013;60(5):583-90. Epub 2013 Jan 5.

41.

Altered of apoptotic markers of both extrinsic and intrinsic pathways induced by hepatitis C virus infection in peripheral blood mononuclear cells.

Albertoni G, Arnoni CP, Latini FR, Andrade SS, Araújo PR, Rodrigues FK, Rozenchan PB, Mendes-Correa MC, Leite OH, Schor N, Girão MJ, Barreto JA.

Virol J. 2012 Dec 20;9:314. doi: 10.1186/1743-422X-9-314.

42.

Correlations of CTLA-4 gene polymorphisms and hepatitis C chronic infection.

Danilovic DL, Mendes-Correa MC, Lima EU, Zambrini H, K Barros R, Marui S.

Liver Int. 2012 May;32(5):803-8. doi: 10.1111/j.1478-3231.2011.02694.x. Epub 2011 Dec 4.

PMID:
22136395
43.

Thyroid hormonal disturbances related to treatment of hepatitis C with interferon-alpha and ribavirin.

Danilovic DL, Mendes-Correa MC, Chammas MC, Zambrini H, Marui S.

Clinics (Sao Paulo). 2011;66(10):1757-63.

44.

Hepatitis delta in HIV/HBV co-infected patients in Brazil: is it important?

Mendes-Correa MC, Gomes-Gouvêa MS, Alvarado-Mora MV, Da Silva MH, Lázari C, Cavalcanti NC, Alonso FK, Carpinelli CC, Uip DE, Pinho JR.

Int J Infect Dis. 2011 Dec;15(12):e828-32. doi: 10.1016/j.ijid.2011.08.003. Epub 2011 Oct 13.

45.

Predictors of HBeAg status and hepatitis B viraemia in HIV-infected patients with chronic hepatitis B in the HAART era in Brazil.

Mendes-Correa MC, Pinho JR, Gomes-Gouvea MS, da Silva AC, Guastini CF, Martins LG, Leite AG, Silva MH, Gianini RJ, Uip DE.

BMC Infect Dis. 2011 Sep 20;11:247. doi: 10.1186/1471-2334-11-247.

46.

Hepatitis Delta virus genotype 8 infection in Northeast Brazil: inheritance from African slaves?

Barros LM, Gomes-Gouvêa MS, Pinho JR, Alvarado-Mora MV, Dos Santos A, Mendes-Corrêa MC, Caldas AJ, Sousa MT, Santos MD, Ferreira AS.

Virus Res. 2011 Sep;160(1-2):333-9. doi: 10.1016/j.virusres.2011.07.006. Epub 2011 Jul 21.

47.

Pegylated interferon/ribavirin-associated sudden hearing loss in a patient with chronic hepatitis C in Brazil.

Mendes-Corrêa MC, Bittar RS, Salmito N, Oiticica J.

Braz J Infect Dis. 2011 Jan-Feb;15(1):87-9.

48.

Hepatitis B genotype G and high frequency of lamivudine-resistance mutations among human immunodeficiency virus/hepatitis B virus co-infected patients in Brazil.

Silva AC, Spina AM, Lemos MF, Oba IT, Guastini Cde F, Gomes-Gouvêa MS, Pinho JR, Mendes-Correa MC.

Mem Inst Oswaldo Cruz. 2010 Sep;105(6):770-8.

49.

Barriers to treatment of hepatitis C in HIV/HCV coinfected adults in Brazil.

Mendes-Corrêa MC, Martins LG, Ferreira PA, Tenore S, Leite OH, Leite AG, Cavalcante AJ, Shimose M, Silva MH, Uip DE.

Braz J Infect Dis. 2010 May-Jun;14(3):237-41. Erratum in: Braz J Infect Dis. 2016 Mar-Apr;20(2):226. Ferreira, P A [added].

50.

High frequency of lamivudine resistance mutations in Brazilian patients co-infected with HIV and hepatitis B.

Mendes-Correa MC, Pinho JR, Locarnini S, Yuen L, Sitnik R, Santana RA, Gomes-Gouvêa MS, Leite OM, Martins LG, Silva MH, Gianini RJ, Uip DE.

J Med Virol. 2010 Sep;82(9):1481-8. doi: 10.1002/jmv.21845.

PMID:
20648600

Supplemental Content

Loading ...
Support Center